Safety and effectiveness of pembrolizumab monotherapy in Japanese patients with unresectable urothelial carcinoma: a nation-wide post-marketing surveillance

Safety and effectiveness of pembrolizumab monotherapy in Japanese patients with unresectable urothelial carcinoma: a nation-wide post-marketing surveillance

Abstract Background This study was conducted to identify factors associated with the safety and effectiveness of pembrolizumab in Japanese patients with unresectable urothelial carcinoma and to confirm the real-world safety and effectiveness of pembrolizumab in Japanese patients. Methods This multic...

Full description

Bibliographic Details
Main Authors: Hiroyuki Nishiyama, Yu Tanaka, Masahiro Hamada, Masahiko Ozaki, Toshihiko Minegishi, Yuichiro Ito, Shinichiroh Maekawa, Nobuyuki Yamamoto
Format: Article
Language:English
Published: BMC 2023-06-01
Series:BMC Cancer
Subjects:
Japanese patients
Pembrolizumab
Post-marketing surveillance
Unresectable urothelial carcinoma
Online Access:https://doi.org/10.1186/s12885-023-10930-2

Internet

https://doi.org/10.1186/s12885-023-10930-2

Similar Items